Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00976508
What this trial is testing

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

Who this might be right for
Colorectal NeoplasmsLung NeoplasmsBreast Neoplasms+2 more
Pfizer 24
Not applicableStudy completedNCT03542097
What this trial is testing

Assessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and Irinotecan

Who this might be right for
Ewing Sarcoma Family of Tumors
Istituto Ortopedico Rizzoli 82
Not applicableLooking for participantsNCT06029218
What this trial is testing

Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy

Who this might be right for
ChordomaChondrosarcomaEwing Sarcoma+1 more
Centre Antoine Lacassagne 106
Testing effectiveness (Phase 2)Study completedNCT00019123
What this trial is testing

Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02239861
What this trial is testing

TAA-Specific CTLS for Solid Tumors (TACTASOM)

Who this might be right for
Rhabdomyosarcoma
Baylor College of Medicine 16
Testing effectiveness (Phase 2)Looking for participantsNCT07028086
What this trial is testing

VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma

Who this might be right for
Acute Myeloid LeukemiaMyeloid Sarcoma
Ruijin Hospital 48
Not applicableStudy completedNCT05631379
What this trial is testing

Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma

Who this might be right for
Retroperitoneal SarcomaBody CompositionMalnutrition+3 more
Institute of Oncology Ljubljana 100
Testing effectiveness (Phase 2)Looking for participantsNCT06778603
What this trial is testing

B7-H3 NIR Imaging for Osteosarcoma Surgery

Who this might be right for
OsteosarcomaResection MarginsB7-H3 Probe+1 more
Peking University People's Hospital 32
Early research (Phase 1)Study completedNCT00003023
What this trial is testing

Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer

Who this might be right for
NeuroblastomaSarcoma
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)UnknownNCT05193188
What this trial is testing

Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma

Who this might be right for
Chondrosarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 70
Testing effectiveness (Phase 2)Looking for participantsNCT04072042
What this trial is testing

BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma

Who this might be right for
Sarcoma
Ruijin Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05019703
What this trial is testing

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

Who this might be right for
Locally Advanced OsteosarcomaMetastatic OsteosarcomaRecurrent Osteosarcoma+2 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT07064018
What this trial is testing

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

Who this might be right for
Soft-tissue SarcomaTriple Negative Breast CancerNon-small Cell Lung Cancer+3 more
University of California, Irvine 67
Early research (Phase 1)Ended earlyNCT05943990
What this trial is testing

Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Who this might be right for
Neoplasms
Adaptimmune 5
Not applicableUnknownNCT05171413
What this trial is testing

Predictive Models of Treatment Responses and Survival Outcomes in Patients With Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
West China Hospital 800
Early research (Phase 1)UnknownNCT04316091
What this trial is testing

A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma

Who this might be right for
Osteosarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Early research (Phase 1)Study completedNCT00634504
What this trial is testing

Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze

Who this might be right for
OsteosarcomaLeukemiaLymphoma
BTG International Inc. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06943521
What this trial is testing

MT-4561 in Patients With Various Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer+13 more
Tanabe Pharma America, Inc. 27
Early research (Phase 1)Active Not RecruitingNCT05691504
What this trial is testing

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more
National Cancer Institute (NCI) 42
Next Page